Cogendx

CogenDx enables clinicians to personalize treatment decisions for patients using state-of-the-art molecular diagnostic technology. Our portfolio includes a proprietary DNA-based solution that helps clinicians rapidly determine course of therapy for patients with suspected wound infections. We also offer genetic testing that helps predict response to commonly prescribed medications and determine genetic risks underlying potential surgical complications. More information can be found at CogenDx is a brand name under Millennium Health. The CogenDx logo is a service mark or registered service mark of Millennium Health, LLC or its subsidiaries in the United States and other Countries. All other trademarks used herein are the property of their respective owners. This clinical laboratory developed test (LDT) was developed and its performance characteristics determined by Millennium Health, LLC and has not been cleared or approved by the US Food and Drug Administration (FDA). This LDT is a clinical test and its results should be used with other clinical observations and diagnostic findings for patient case management. Millennium Health, LLC maintains certification in accordance with Clinical Laboratory Improvement Amendments of 1988 and is accredited by the College of American Pathologists.*DxSurgical is not intended to diagnose disease or illness. It is a genetic test that detects the presence of certain DNA variations that may impact response to medications used in the surgical setting or which potentially contribute to risk of certain surgical complications.